A prospective open-label pilot study from Mayo Clinic presented at the 2026 AAN Annual Meeting in Chicago has found that high-dose rimegepant, an oral CGRP

In a packed session at the 2026 Annual Meeting of the American Academy of Neurology, leading specialists presented compelling evidence that small fiber neuropathy (SFN)

Headache medicine is being quietly rewritten, and Liza Smirnoff, MD, of the University of Miami laid out the case today at the American Academy of

In a wide-ranging “Updates in Epilepsy” session delivered today at the American Academy of Neurology (AAN) Annual Meeting, Jessica Fesler, MD, MEd, FAES, of the

Functional MRI study from Taipei and Mayo Clinic identifies locus coeruleus–substantia nigra connectivity as the neural substrate of restlessness in cluster headache. CHICAGO — Restlessness

Investigators at Vanderbilt University Medical Center have reported preliminary validation of a novel, remotely administered screening tool for visuospatial and executive function in adults with

Functional MRI study from Taipei and Mayo Clinic identifies locus coeruleus–substantia nigra connectivity as the neural substrate of restlessness in cluster headache. CHICAGO — Restlessness

Praxis Precision Medicines has reported encouraging results from its first-in-human clinical trial of vormatrigine (PRAX-628), a novel drug being developed for epilepsy treatment. This session

A groundbreaking clinical trial has been launched to evaluate BHV-7000, a novel treatment for idiopathic generalized epilepsy (IGE) with generalized tonic-clonic seizures, using an innovative

A groundbreaking long-term clinical trial has demonstrated that brivaracetam, when used as an add-on therapy, shows sustained effectiveness and safety in children suffering from primary